Galapagos has changed its name to Lakefront Biotherapeutics. This page will remain live for continuity during the transition. For all future Company updates, please follow our official new LinkedIn page: https://www.linkedin.com/company/lakefront-bio
| Website | http://www.glpg.com |
| Revenue | $267.9 million |
| Employees | 693 (292 on RocketReach) |
| Founded | 1999 |
| Industry | Biotechnology Research |
| Competitors | Roche, Novartis, AbbVie, Pfizer, AstraZeneca, Amgen, Boehringer Ingelheim, Gilead Sciences, Vertex Pharmaceuticals, Receptos, a wholly-owned subsidiary of Celgene +50 more (view full list) |
Looking for a particular Galapagos employee's phone or email?
The Galapagos annual revenue was $267.9 million in 2026.
Sooin Kwon is the Chief Business Officer of Galapagos.
292 people are employed at Galapagos.